Benvenuti sul sito web di Farmacovigilanza

Feed rss AIFA: Notizia

27/04/2026

Aggiornamento "Diario di bordo sulla Trasparenza"

Ultime notizie

26/03/2026

C’è un legame tra fatigue ed eventi avversi correlati alle terapie oncologiche?

Biblioteca Virtuale per la Salute – Piemonte

24/04/2026

Newsletter trimestrale Medicina di Genere – aprile 2026

Agendas and minutes

28/04/2026

Agenda - European Medicines Regulatory Network workshop on Geographic Atrophy endpoints

Consumer Updates RSS Feed

20/04/2026

Animal Welfare, Testing and Research of FDA-Regulated Products

Regulatory and procedural guidelines (human and veterinary)

28/04/2026

Guidance on the details of the classification of variations requiring assessment according to Article 62 of Regulation (EU) 2019/6 for veterinary medicinal products and on the documentation to be submitted pursuant to those variations

Scientific guidelines (human and veterinary)

24/04/2026

Draft concept paper on the development for guidance on demonstration of biosimilarity of biological veterinary medicinal products

Paediatric investigation plans

23/04/2026

Opinion/decision on a Paediatric investigation plan (PIP): Skyrizi, risankizumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Dermatology, PIP number: P/0497/2022

Orphan designations

24/04/2026

Orphan designation: diazoxide choline Treatment of Prader-Willi syndrome, 12/10/2017 Positive

New medicines and opinions: human

24/04/2026

Human medicines European public assessment report (EPAR): Cenrifki, tolebrutinib, Status: Opinion

MedWatch Safety Alerts RSS Feed

24/04/2026

Early Alert: Automated Compounding System Issue from Omnicell

What's New: Drugs RSS Feed

28/04/2026

FDA Pharmaceutical Quality Training Modules

FDA Drug Safety Podcasts

02/01/2025

Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis